Home/Filings/4/0001104659-23-046987
4//SEC Filing

Matthews Andrea 4

Accession 0001104659-23-046987

CIK 0001454789other

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 8:10 AM ET

Size

5.7 KB

Accession

0001104659-23-046987

Insider Transaction Report

Form 4
Period: 2023-04-17
Matthews Andrea
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-04-17+20,00020,000 total
    Exercise: $10.82Exp: 2033-04-16Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]This option was granted on April 17, 2023 and is subject to vesting over a four-year period, with 25% of the 20,000 shares underlying the option upon grant vesting on the first anniversary of April 17, 2023 and the remainder vesting over the ensuing three years in equal monthly installments.

Issuer

Astria Therapeutics, Inc.

CIK 0001454789

Entity typeother

Related Parties

1
  • filerCIK 0001973349

Filing Metadata

Form type
4
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 8:10 AM ET
Size
5.7 KB